Five Upcoming Startup Events In Delhi By: Vijay Soni, PhD | Founder & C.E.O. Scipreneur (1) Startups Founders & Investors Meet Sat, 22 Apr 2017 12:00PM – 3:00PM By Eduwhiz .in at WorkWings , Delhi Rs 500 Description Eduwhiz brings Startup Founders & Investors 3.0. Applications open for Startups at Please [..]
Microscopes from droplets: MIT Research Source: Jennifer Chu | MIT News Office March 25, 2017 Liquid droplets are natural magnifiers. Look inside a single drop of water, and you are likely to see a reflection of the world around you, close up and distended as you’d see in a crystal [..]
New Discovery Towards Faster Data System : Novel Direction For “Valleytronic” Devices By: Helen Knight | MIT News correspondent March 25, 2017 Faster, more efficient data storage and computer logic systems could be on the horizon thanks to a new way of tuning electronic energy levels in two-dimensional films of crystal, discovered [..]
FDA Approves Xadago® (Safinamide) For Parkinson’s Disease By: Newron Pharmaceuticals News March 23, 2017 Newron Pharmaceuticals S.p.A. (“Newron”, SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, and its partners Zambon S.p.A. and US WorldMeds, [..]
FDA Approved Kisqali® (ribociclib, LEE011) of Novartis for HR+/HER2- Metastatic Breast Cancer The digital press release with multimedia content can be accessed here March 17, 2017 By : Novartis News At this interim analysis, Kisqali plus letrozole reduced risk of disease progression or death by 44% over letrozole alone, [..]
FDA Approved Lexicon Pharma’s Xermelo® Against Carcinoid Syndrome Diarrhea Source: FDA News and Lexpharma News March 9, 2017 The U.S. Food and Drug Administration today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled. Carcinoid [..]
GSK’s MUSCA Study Shows Nucala® Found Significantly Effective In Severe Asthma Patients Issued From: London UK – LSE Announcement GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and [..]
Roche’s Perjeta® Regimen For Breast Cancer Found to Greatly Extend Patients’ Lives: Phase III APHINITY study By: Basel Roche News Perjeta plus Herceptin and chemotherapy showed a statistically significant improvement in invasive disease-free survival (iDFS) for people with HER2-positive early breast cancer (eBC) compared to Herceptin and chemotherapy alone Data will be discussed with [..]
Drug Treatment Could Combat Hearing Loss By: Anne Trafton | MIT News Office March 05, 2017 Within the inner ear, thousands of hair cells detect sound waves and translate them into nerve signals that allow us to hear speech, music, and other everyday sounds. Damage to these cells is one [..]
Tiny Fibers Open New Windows Into The Brain March 05, 2017 David L. Chandler | MIT News Office For the first time ever, a single flexible fiber no bigger than a human hair has successfully delivered a combination of optical, electrical, and chemical signals back and forth into the brain, [..]
Startup Events In USA : March 2017 By: Vijay Soni, PhD | Founder & C.E.O. Scipreneur Whether you are starting a business just now, or you are already running a company, or you are just curious about what might be the business, entrepreneurship, technology, or digital marketing trends of tomorrow, [..]
FDA Clears Test to Help Manage Antibiotic Treatment For Lower Respiratory Tract Infections And Sepsis Source: BioMérieux NEWS March 1, 2017 bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S [..]
FDA Approved Marketing of for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit Source: Accelerate Diagnostic, Inc. March 1, 2017 Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for [..]
Copyright © 2024 | WordPress Theme by MH Themes